Terumo : Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)
August 29, 2018 at 05:12 am EDT
Share
August 29, 2018
Company name : Terumo Corporation
Representative : Shinjiro Sato, President and CEO Code No. : 4543, TSE Section 1
Notice Concerning the Determination of Details of Issuance of Stock Options
(Share Warrants)
Terumo Corporation determined the undetermined part concerning the issuance of Stock Options (Share Warrants) resolved at the Board of Directors held on August 8, 2018.
I. Terumo Corporation No.6 Share Warrants A-Type
1. Total number of Share Warrants to be allocated
8,184 warrants
2. The amount to be paid for subscription rights to Share Warrants
11,730 yen per Share Warrant (5,865 yen per Share)
3. Persons to whom Share Warrants are to be allocated, the number of such persons, and the number of Share Warrants to be allocated
Persons to whom Share Warrants are to be allocated
Number of persons
Number of Share Warrants to be allocated
Directors of the Company (excluding Audit/Supervisory Committee members and Independent Directors)
5 persons
8,184 warrants
II. Terumo Corporation No.6 Share Warrants B-Type
1. Total number of Share Warrants to be allocated
10,424 warrants
2. The amount to be paid for subscription rights to Share Warrants
11,606 yen per Share Warrant (5,803 yen per Share)
3. Persons to whom Share Warrants are to be allocated, the number of such persons, and the number of Share Warrants to be allocated
Persons to whom Share Warrants are to be allocated
Number of persons
Number of Share Warrants to be allocated
Executive Officers of the Company
28 persons
9,149 warrants
Fellows of the Company
5 persons
1,275 warrants
Attachments
Original document
Permalink
Disclaimer
Terumo Corporation published this content on 29 August 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 August 2018 09:11:07 UTC
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
TERUMO CORPORATION 
